By Kelly Cloonan
Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public.
The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier.
Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago.
New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales.
For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 14, 2025 16:40 ET (20:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。